Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-14-078157

Director sold 11,933 shares at an average $11.23 ($134,035)

  • Director acquired 23,762 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nash Duane · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2014-12-23 Grant or award : show line 1 in the form +23,762 $11.54 $274,213 23,762 D
2014-12-24 Sale : show line 2 in the form −6,764 $11.26 $76,189 16,998 D
2014-12-26 Sale : show line 3 in the form −5,169 $11.19 $57,846 11,829 D
Open-market sales · 11,933 sh · avg $11.23 · $134,035
Loading xslF345X03/doc4.xml…